KR100854700B1 - 홍삼 농축액을 함유한 기능성 음료 - Google Patents
홍삼 농축액을 함유한 기능성 음료 Download PDFInfo
- Publication number
- KR100854700B1 KR100854700B1 KR1020080004883A KR20080004883A KR100854700B1 KR 100854700 B1 KR100854700 B1 KR 100854700B1 KR 1020080004883 A KR1020080004883 A KR 1020080004883A KR 20080004883 A KR20080004883 A KR 20080004883A KR 100854700 B1 KR100854700 B1 KR 100854700B1
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- water
- deep
- functional beverage
- iii
- Prior art date
Links
- 235000020510 functional beverage Nutrition 0.000 title claims description 23
- 235000008434 ginseng Nutrition 0.000 title description 27
- 241000208340 Araliaceae Species 0.000 title description 26
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title description 26
- 235000003140 Panax quinquefolius Nutrition 0.000 title description 26
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 118
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000013535 sea water Substances 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 56
- 239000012141 concentrate Substances 0.000 claims abstract description 42
- 238000010438 heat treatment Methods 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 19
- 239000012535 impurity Substances 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 13
- 239000008213 purified water Substances 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 229940107131 ginseng root Drugs 0.000 claims abstract description 4
- 229920002472 Starch Polymers 0.000 claims description 16
- 235000019698 starch Nutrition 0.000 claims description 16
- 239000008107 starch Substances 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 230000032683 aging Effects 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000007865 diluting Methods 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 229910010272 inorganic material Inorganic materials 0.000 abstract 1
- 239000011147 inorganic material Substances 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 description 23
- 239000008239 natural water Substances 0.000 description 21
- 239000011707 mineral Substances 0.000 description 20
- 235000010755 mineral Nutrition 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 19
- 238000011049 filling Methods 0.000 description 19
- 229910052500 inorganic mineral Inorganic materials 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 229930182490 saponin Natural products 0.000 description 16
- 150000007949 saponins Chemical class 0.000 description 16
- 235000017709 saponins Nutrition 0.000 description 16
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 14
- 229930182494 ginsenoside Natural products 0.000 description 12
- 238000004659 sterilization and disinfection Methods 0.000 description 12
- 239000000654 additive Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 235000003599 food sweetener Nutrition 0.000 description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000003765 sweetening agent Substances 0.000 description 8
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000012085 test solution Substances 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 238000000909 electrodialysis Methods 0.000 description 6
- 229940089161 ginsenoside Drugs 0.000 description 6
- 238000001223 reverse osmosis Methods 0.000 description 6
- 239000002352 surface water Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000000588 Interleukin-2 Human genes 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000010612 desalination reaction Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 108010062580 Concanavalin A Proteins 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000003014 ion exchange membrane Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000003660 reticulum Anatomy 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000004989 spleen cell Anatomy 0.000 description 3
- 229940104230 thymidine Drugs 0.000 description 3
- 238000007738 vacuum evaporation Methods 0.000 description 3
- 238000009423 ventilation Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKSTLPRTWFEV-OLZOCXBDSA-N Deoxygomisin A Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-OLZOCXBDSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- -1 starch Chemical class 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 101800000112 Acidic peptide Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- RTZKSTLPRTWFEV-UHFFFAOYSA-N Isokadsuranin Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)C(C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000005880 cancer cell killing Effects 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- BVMLGLOHSDNEJG-UHFFFAOYSA-N neglschisandrin E Natural products C1C(C)C(C)CC2=CC(O)=C(OC)C(OC)=C2C2=C1C=C1OCOC1=C2OC BVMLGLOHSDNEJG-UHFFFAOYSA-N 0.000 description 1
- VXAPDXVBDZRZKP-UHFFFAOYSA-N nitric acid phosphoric acid Chemical compound O[N+]([O-])=O.OP(O)(O)=O VXAPDXVBDZRZKP-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
구분 | 수온 | 염분 | pH | 영양염 | 용존산소(㎎/㎖) | ||
인산염 | 질산염 | 규산염 | |||||
동해심층수(고성) | 1.52~1.9 | 33.72~33.94 | 7.19~7.90 | 1.7~4.3 | 3.6~13.3 | 72.0~108.0 | 9.13~9.47 |
일본고치현심층수 | 8.1~9.8 | 34.3~34.4 | 7.8~7.9 | 1.1~2.0 | 12.1~26.0 | 33.9~56.8 | 4.1~4.8 |
일본 도야마현 심층수 | 1~2 | 34.1 | 7.74 | 1.2~1.8 | 14~26 | 30~38 | 5.0~6.0 |
일본 오끼나요현 심층수 | 9.0 | 34.71 | 7.93 | 3.05 | 21.89 | 44.81 | |
미국 하와이 심층수 | 8.2~10.7 | 34.37~34.29 | 7.45~7.64 | 2.89~3.15 | 39.03~40.86 | 74.56~79.2 | 1.24~1.45 |
실시예11 | 실시예12 | 실시예13 | 실시예14 | 실시예15 | 실시예16 | |
홍삼농축액(g) | 1 | 3 | 6 | 3 | 6 | 10 |
물(g) | 98 | 94 | 89 | 98 | 94 | 89 |
심층수(g) | 1 | 2 | 3 | 1 | 2 | 3 |
산소(㎎/ℓ) | 30 | 45 | 60 |
연령대별 선호도 (실시예 12) | |||||
관능시험 | 20대 | 30대 | 40대 | 50대 | 60대 |
향 | ☆ | ● | ☆ | ★ | ★ |
맛 | ● | ☆ | ☆ | ☆ | ★ |
색 | ☆ | ● | ☆ | ★ | ★ |
연령대별 선호도 (실시예 15) | |||||
관능시험 | 20대 | 30대 | 40대 | 50대 | 60대 |
향 | ● | ● | ☆ | ☆ | ★ |
맛 | ☆ | ● | ● | ☆ | ★ |
색 | ● | ● | ● | ● | ★ |
시간(분) | 물(%) | Acetonitrile(%) |
0~10 | 80 | 20 |
10~40 | 80→68 | 20→32 |
40~48 | 68→58 | 32→42 |
48~50 | 58→0 | 42→100 |
50~60 | 0 | 100 |
60~62 | 0→80 | 100→20 |
62~70 | 80 | 20 |
구분 | 임파구 증식능(SI) |
대조군 | PBS : 1.0 |
양성대조군 | Con A : 40.9(2.5 ㎍/㎖) |
실시예 1 | 22.4(500 ㎍/㎖) |
구분 | LAK 세포생성능(lytic units) |
대조군 | PBS : 1.0 |
양성대조군 | IL-2 : 54.6(30 units) |
실시예 1 | 9.7(100 ㎍/㎖) |
Claims (16)
- 삭제
- ⅰ) 원료가 되는 홍삼을 선별 및 열처리하는 단계;ⅱ) 상기 선별된 홍삼에 정제수를 혼합하여 고온에서 추출하는 단계;ⅲ) 상기 추출된 홍삼액을 가열 및 살균처리하는 단계;ⅳ) 상기 살균처리된 홍삼 추출액을 냉각시키고 불순물을 분리제거하는 단계;ⅴ) 상기 불순물이 제거된 홍삼 추출액을 55~65℃의 저온 진공농축방법으로 농축하여 #100~140체에서 불순물을 제거하고 숙성하는 홍삼 추출액의 농축 및 숙성 단계; 및ⅵ) 상기 홍삼 추출액의 당분 및 전분함량을 측정하는 단계를 포함하여 제조된 홍삼 농축액 및,동해 심층수를 포함하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅰ) 단계의 선별 및 열처리는 세삼/증삼/건조/정형/선별 공정 및 100~120℃의 열처리 공정으로 이루어지는 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅱ) 단계의 정제수는 원료 홍삼 질량의 4~8배인 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅱ) 단계의 고온은 증기 간접 가열방식으로 80~95℃인 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅱ) 단계의 추출은 연속식 탱크에서 5~8회 수행하거나 배치식 탱크에서 2~5회 수행하는 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅲ) 단계의 가열 및 살균처리는 90~100℃에서 가열 및 순간 냉각/가열 방법으로 살균처리하는 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅳ) 단계의 냉각은 0~10℃에서 수행하는 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅳ) 단계의 불순물의 제거는 5,000~8,000 rpm의 원심분리기를 이용하여 10~30 ℓ/min의 유속으로 냉각 호화된 전분질 및 이물 찌꺼기를 제거하는 것을 특징으로 하는 기능성 음료.
- 삭제
- 제 2항에 있어서, 상기 ⅵ) 단계의 당분 및 전분함량 측정은 40~75 브릭스의 당분 함량 및 2~3% 전분 함량인 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 ⅵ) 단계 이후에 홍삼 농축액의 색도, 수분함량 및 미생물 분석을 수행하며, 상기 색도는 0.20~0.50이고, 수분함량은 30~45%이고, 미생물은 100/g 이하인 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 원료가 되는 홍삼은 홍삼근: 홍미삼 의비가 1: 1~0.2로 함유되는 것을 특징으로 하는 기능성 음료.
- 제 2항에 있어서, 상기 기능성 음료는 홍삼 농축액 질량의 0.1 ~ 5배의 수심 200 m이하에서 취수한 동해 심층수를 첨가하고, 이를 5 ~ 100배의 정제수로 희석하여 제조되는 것을 특징으로 하는 기능성 음료.
- 제 14항에 있어서, 상기 동해 심층수는 농축 처리된 심층수를 함유하는 것을 특징으로 하는 기능성 음료.
- 제 14항에 있어서, 상기 동해 심층수는 탈염 처리된 심층수를 함유하는 것을 특징으로 하는 기능성 음료.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080004883A KR100854700B1 (ko) | 2008-01-16 | 2008-01-16 | 홍삼 농축액을 함유한 기능성 음료 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080004883A KR100854700B1 (ko) | 2008-01-16 | 2008-01-16 | 홍삼 농축액을 함유한 기능성 음료 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100854700B1 true KR100854700B1 (ko) | 2008-08-27 |
Family
ID=39878744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080004883A KR100854700B1 (ko) | 2008-01-16 | 2008-01-16 | 홍삼 농축액을 함유한 기능성 음료 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100854700B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101505100B1 (ko) * | 2013-09-24 | 2015-03-25 | 주식회사 천지양 | 진세노사이드 함량이 증가된 홍삼음료 및 그 제조 방법 |
KR102136875B1 (ko) * | 2019-01-31 | 2020-07-22 | 주식회사 참든건강과학 농업회사법인 | 비트 주스의 제조방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037380A (ko) * | 2001-11-03 | 2003-05-14 | 주식회사 케이티앤지 | 홍삼농축액을 이용한 건강보조식품 및 그의 제조방법 |
KR20040026276A (ko) * | 2002-09-23 | 2004-03-31 | 김우영 | 당뇨병 치료 및 예방에 효과적인 건강보조식품 및 이의제조방법 |
KR20040081932A (ko) * | 2003-03-17 | 2004-09-23 | 설혜영 | 홍삼/인삼 신속추출 및 농축액 증대 |
-
2008
- 2008-01-16 KR KR1020080004883A patent/KR100854700B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037380A (ko) * | 2001-11-03 | 2003-05-14 | 주식회사 케이티앤지 | 홍삼농축액을 이용한 건강보조식품 및 그의 제조방법 |
KR20040026276A (ko) * | 2002-09-23 | 2004-03-31 | 김우영 | 당뇨병 치료 및 예방에 효과적인 건강보조식품 및 이의제조방법 |
KR20040081932A (ko) * | 2003-03-17 | 2004-09-23 | 설혜영 | 홍삼/인삼 신속추출 및 농축액 증대 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101505100B1 (ko) * | 2013-09-24 | 2015-03-25 | 주식회사 천지양 | 진세노사이드 함량이 증가된 홍삼음료 및 그 제조 방법 |
KR102136875B1 (ko) * | 2019-01-31 | 2020-07-22 | 주식회사 참든건강과학 농업회사법인 | 비트 주스의 제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200352206A1 (en) | Composition and method for mushroom mycelial compound and botanical mixture | |
JP6876724B2 (ja) | 塩生植物由来の機能性が強化した脱塩栄養組成物とその製造方法 | |
KR100854685B1 (ko) | 홍삼 농축액의 제조방법 및 상기 방법에 의하여 제조된홍삼 농축액 | |
KR101974723B1 (ko) | 락토바실러스 플란타륨 균주와 락토바실러스 브레비스 균주로 혼합발효되고 우수한 기호성과 증진된 가바 함량 및 증진된 기능성을 갖는 여주-과채 발효음료 | |
KR101793933B1 (ko) | 항산화활성 및 미백효과가 있는 기능성 고추장 및 그 제조방법 | |
KR100854701B1 (ko) | 홍삼 농축액을 함유한 기능성 음료 | |
CN112704210A (zh) | 一种利用西红柿制备的果蔬酸汤汁及其制备方法和应用 | |
EP3673038A1 (en) | A method for producing a polyphenolic composition from barley malt | |
KR101759494B1 (ko) | 항고혈압 저염 간장의 제조방법 | |
CN102334707A (zh) | 一种松茸饮料及其制备方法 | |
KR100854700B1 (ko) | 홍삼 농축액을 함유한 기능성 음료 | |
KR101394358B1 (ko) | 숙취 해소용 조성물 | |
KR100854692B1 (ko) | 미크론 이하 크기의 홍삼 나노분말을 함유한 기능성 음료 | |
KR100854688B1 (ko) | 홍삼 농축액을 함유한 기능성 음료 | |
KR100854691B1 (ko) | 미크론 이하 크기의 홍삼 나노성분을 함유한 기능성 음료 | |
KR20190006702A (ko) | 모과, 박하, 산수유 함유 기능성음료의 제조방법 및 이로부터 제조된 기능성음료 | |
KR101341162B1 (ko) | 소나무 피 추출액을 이용한 음료 첨가물 및 그 제조방법 | |
KR100854690B1 (ko) | 미크론 이하 크기의 홍삼 나노입자를 함유한 기능성 음료 | |
CN108477361A (zh) | 一种黄秋葵籽中药咖啡饮品及其制备方法 | |
KR101701809B1 (ko) | 흑마늘 함유 홍삼 유음료 및 그 제조방법 | |
RU2779422C1 (ru) | Безалкогольный напиток на основе ферментированного сока рябины черноплодной | |
KR101865819B1 (ko) | 오미자 발효물 및 호두를 함유하는 정제를 포함하는 뇌질환 예방 또는 치료용 약학적 조성물 | |
KR101164791B1 (ko) | 막걸리를 이용한 홍삼액의 제조방법 | |
CN109468207B (zh) | 一种人参玉竹酒及其制备方法 | |
CN107418840A (zh) | 一种半固态发酵制备茶酒的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120730 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130722 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140804 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150723 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160801 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170728 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190718 Year of fee payment: 12 |